Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Osprey Pharmaceuticals USA
AddedFeb 17, 2024
UpdatedJun 18, 2026
Osprey Pharmaceuticals USA

Osprey Pharmaceuticals USA

Series A

Osprey Pharmaceuticals USA: Innovating protein therapeutics for inflammatory and immune diseases.

HQ
San Francisco, CA, US
Founded
1998
Overview
Compare
Fundraising
Employees
Website

Osprey Pharmaceuticals USA is a clinical-stage company founded with the mission to innovate and develop novel protein therapeutics aimed at treating inflammatory and immune diseases. The company's vision is to advance healthcare by providing effective and targeted treatments for conditions that currently have limited therapeutic options. Osprey Pharmaceuticals focuses on leveraging cutting-edge biotechnology to create solutions that address significant unmet medical needs in the market.

Notable figures associated with Osprey Pharmaceuticals include leading scientists and industry experts in the field of biotechnology and pharmaceuticals. The company has garnered attention from key investors who are committed to advancing medical science. Osprey Pharmaceuticals has achieved significant milestones in its clinical trials, demonstrating promising results that have the potential to transform the treatment landscape for inflammatory and immune diseases. The overall impact of Osprey Pharmaceuticals lies in its dedication to improving patient outcomes through innovative therapeutic approaches.

Osprey Pharmaceuticals USA - Similar Companies

Woolsey Pharmaceuticals logo

Woolsey Pharmaceuticals

woolseypharma.com

Spyre Therapeutics logo

Spyre Therapeutics

aeglea.com

Resolvyx Pharmaceuticals logo

Resolvyx Pharmaceuticals

Anthera Pharmaceuticals logo

Anthera Pharmaceuticals

anthera.com

Omeros logo

Omeros

omeros.com

Epirus Biopharmaceuticals logo

Epirus Biopharmaceuticals

Halia Therapeutics logo

Halia Therapeutics

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Exalys Therapeutics logo

Exalys Therapeutics

IpiNovyx Bio logo

IpiNovyx Bio

Visiox logo

Visiox

visioxpharma.com

Odyssey Therapeutics logo

Odyssey Therapeutics

Bluejay Therapeutics logo

Bluejay Therapeutics

bluejaytx.com

Thesan Pharmaceuticals logo

Thesan Pharmaceuticals

thesanpharma.com

Chase Therapeutics logo

Chase Therapeutics

Osprey Pharmaceuticals USA - Quick Facts

Who are Osprey Pharmaceuticals USA's competitors?

Companies similar to Osprey Pharmaceuticals USA include Woolsey Pharmaceuticals, Spyre Therapeutics, Resolvyx Pharmaceuticals and Anthera Pharmaceuticals.

When was Osprey Pharmaceuticals USA founded?

Osprey Pharmaceuticals USA was founded in 1998.

Where is Osprey Pharmaceuticals USA's headquarters located?

Osprey Pharmaceuticals USA's headquarters is located in San Francisco, CA, US.

When was Osprey Pharmaceuticals USA's last funding round?

Osprey Pharmaceuticals USA's most recent funding round was for $3.8M (USD) in May 2009.

How much has Osprey Pharmaceuticals USA raised to-date?

As of May 27, 2009, Osprey Pharmaceuticals USA has raised a total of $29.7M (USD).

How many employees does Osprey Pharmaceuticals USA have?

Osprey Pharmaceuticals USA has 30 employees as of Feb 5, 2024.

Osprey Pharmaceuticals USA - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified